Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector

Annals of Thoracic Surgery

Volumn 62, Issue 2, 1996, Pages 425-434

  Magovern, Christopher J ^a,b   Mack, Charles A ^a,b   Zhang, John ^a,b   Hahn, Rebecca T ^a,b   Ko, Wilson ^a,b   Isom, O Wayne ^a,b   Crystal, Ronald G ^a,b   Rosengart, Todd K ^a,b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; EXPRESSION VECTOR; GENE TARGETING; GENE THERAPY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; TRANSCRIPTION REGULATION; TREATMENT OUTCOME;

EID: 0030217906     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00328-1     Document Type: Article

References (27)

1. 1. Rowland RT, Cleveland JC Jr, Meng X, Harken AH, Brown JM, Potential gene therapy strategies in the treatment of cardiovascular disease. Ann Thorac Surg 1995;60:721-8.
2. 2. Barr E, Carroll J, Kalynych AM, Tripathy SK, Kozarsky K, Wilson JM. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther 1994;1:51-8.
3. 3. Lim CS, Chapman GD, Gammon RS, et al. Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. Circulation 1991;83:2007-11.
4. 4. French BA, Mazur W, Geske RS, Bolli R. Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation 1994;90:2414-24.
5. 5. Von Harsdorf R, Schott RJ, Shen Y, Vatner SF, Mahdave V, Nadal-Ginard B. Gene injection into canine myocardium as a useful model for studying gene expression in the heart of large mammals. Circ Res 1993;72:688-95.
6. 6. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267: 10931-4.
7. 7. Lazarous DF, Scheinowitz M, Shou M, et al. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 1995; 91:145-53.
8. 8. Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992;257:1401-3.
9. 9. Ferrara N, Heinsohn H, Walder CE, Bunting S, Thomas GR. The regulation of blood vessel growth by vascular endothelial growth factor. Ann NY Acad Sci 1995;752:246-56.
10. 10. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res 1994;28:1176-9.
11. 11. Li J, Brown LF, Hibberd MG, Grossman JD, Simons M. VEGF and VEGF receptor expression in acute myocardial infarction model of angiogenesis [Abstract]. Circulation 1995; 92(Suppl 1):713.
12. 12. Banai S, Jaklitsch MT, Shou M, et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994;89:2183-9.
13. 13. Pearlman JD, Hibberd MG, Chuang ML, et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med 1995;1:1085-9.
14. 14. Guzman RJ, Lemarchand P, Crystal RG, Epstein SE, Finkel T. Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res 1993;73:1202-7.
15. 15. Gilgenkrantz H, Duboc D, Juillard V, et al. Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors; role of the immune response. Hum Gene Ther 1995;6:1265-74.
16. 16. Kass-Eisler A, Falck-Pedersen E, Alvira M, et al. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci USA 1993;90:11498-502.
17. 165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo. Circ Res 1995;77:1077-86.
18. 18. Hersh J, Crystal RG, Bewig BB. Modulation of gene expression after replication deficient recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther 1995;2:124-31.
19. 19. Rosenfeld MA, Siegfried W, Yoshimura K, et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68:143-55.
20. 20. Crystal RG. Transfer of genes to humans: early lessons and obstacles to success. Science 1995;270:404-10.
21. 21. Vincent N, Ragot T, Gilgenkrantz H, et al. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet 1993;5:130-4.
22. 22. Milano CA, Allen LF, Dolber PC, et al. Marked enhancement in myocardial function resulting from overexpression of a human beta-adrenergic receptor gene. J Thorac Cardiovasc Surg 1995;109:236-41.
23. 23. Qin L, Chavin KD, Ding Y, et al. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Immunosuppression with TGF-beta 1 or vIL-10. Transplantation 1995;59:809-16.
24. 24. Giordano FJ, McKiman MD, Ping P, et al. Reduced myocardial ischemia after recombinant adenovirus mediated in-vivo fibroblast growth factor-5 gene transfer [Abstract]. J Invest Med 1995;3:278A.
25. 25. McDonald P, Hicks MN, Cobbe SM, Prentice H. Gene transfer in models of myocardial ischemia. Ann NY Acad Sci 1995;752:455-9.
26. 26. Muhlhauser J, Jones M, Yamada I, et al. Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors. Gene Ther 1996; 3:145-53.
27. 27. Buttrick PM, Kass A, Kitsis RN, Kaplan ML, Leinwand LA. Behavior of genes directly injected into the rat heart in vivo. Circ Res 1992;70:193-8.